Arpa-h open BAA 2023

Ended Cooperative Agreement Awarded Last action

Award ID
D24AC00040
Recipient
Awarding agency
Obligated
$26,978,959

Award facts

Completion date
Originally
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment The proposal aims to develop two distinct orally ingestible devices that would enable treatments of metabolic diseases that currently require invasive… $0
Original award $26,978,959

Subawards

Subrecipient Amount Awarded
UKU Bio, Inc. Develop physical and/or software medical devices for new classes of oral therapeutics. $4,648,812
Capsulatebio, Inc. Develop scalable manufacturing, safety and efficacy testing, and execution of first clinical trials for new oral therapeutics. $2,348,567
Brigham & Womens Hospital Inc. Characterize the delivery of project's electroceuticals and mRNA therapeutics to the gastrointestinal tract. $2,168,433
The Broad Institute, Inc. Characterize the delivery of electroceuticals and mRNA therapeutics to the gastrointestinal tract. $5,679,574
The Regents Of The University Of Colorado Review ethical issues associated with electroceuticals and oral mRNA technologies and develop an ethics policy. $1,644,461
New York University Identify to what extent developed ingestible device prototypes are able to modulate biological circuits. $1,816,048

Quick answers

Who received award D24AC00040?

D24AC00040 was awarded to Massachusetts Institute Of Technology by Interior Business Center (Office of Policy Management and Budget) on February 1, 2024.

How much is award D24AC00040 worth?

$26,978,959 has been obligated on D24AC00040.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login